SGMT
Sagimet Biosciences Inc. Series A
9.40$
-5.2%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.48 | -0.47 | -0.98 | -1.10 | -1.31 | -1.35 | -1.41 | |
| 0.00 | 0.01 | 0.01 | 0.01 | – | – | – | |
| 0.13 | 0.03 | 0.09 | 0.08 | 0.27 | 0.17 | 0.20 | |
| 0.14 | 0.04 | – | – | – | – | – | |
| 0.03 | 0.00 | 0.00 | 0.19 | -0.05 | -0.03 | -0.03 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.00 | 0.00 | – | -1.44 | 0.69 | -1.97 | 0.14 | |
| -0.15 | – | – | – | – | – | – | |
| 0.83 | 3.11 | 0.44 | 0.00 | 4.74 | 3.34 | 0.01 | |
| 0.36 | 2.64 | -0.54 | -2.55 | 4.12 | 0.02 | -1.26 | |
| -0.48 | -0.47 | -0.98 | -1.10 | -1.31 | -1.35 | -1.41 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.